CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Kalbe Farma Tbk PT Company Snapshot
Kalbe Farma Tbk PT operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Kalbe Farma Tbk PT with three other pharmaceutical manufacturers in Asia: Nichi-Iko Pharmaceutical Company Limited of Japan (2017 sales of 163.37 billion Japanese Yen [US$1.52 billion] of which 100% was Ethical Pharmaceutical), Kobayashi Pharmaceutical Co Ltd of Japan (156.76 billion Japanese Yen [US$1.46 billion] of which 79% was Domestic Manufacture And Sale Of Househo), and Cadila Healthcare Ltd which is based in India (94.30 billion Indian Rupees [US$1.44 billion] of which 100% was Pharmaceutical Products).

Sales Analysis. Kalbe Farma Tbk PT reported sales of 20.18 trillion Indonesian Rupiahs (US$1.47 billion) for the year ending December of 2017. This represents an increase of 4.2% versus 2016, when the company's sales were 19.37 trillion Indonesian Rupiahs. Sales at Kalbe Farma Tbk PT have increased during each of the previous five years (and since 2012, sales have increased a total of 48%). Sales of Nutritionals saw an increase that was more than double the company's growth rate: sales were up 8.7% in 2017, from 5.61 trillion Indonesian Rupiahs to 6.10 trillion Indonesian Rupiahs.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Kalbe Farma Tbk PT
  Stock Performance Chart for Kalbe Farma Tbk PT
 
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 1,595.00
(Figures in Indonesian Rupiahs)
1 Week 1.9%   13 Weeks 11.5%  
4 Weeks -6.5%   52 Weeks 0.9%  
 
Kalbe Farma Tbk PT Key Data:
  Ticker: KLBF Country: Indonesia
  Exchanges: JAK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 20,182,120,166,616
(Year Ending Jan 2018).
Employees: 12,733
  Currency: Indonesian Rupiahs Market Cap: 74,765,819,765,450
  Fiscal Yr Ends: December Shares Outstanding: 46,875,122,110
  Share Type: Ordinary Closely Held Shares: 26,583,510,985
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.